SANGAMO THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested
SANGAMO THERAPEUTICS, INC. (SGMOQ) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested of $3.50 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-18.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested · last filed 2016-02-18
- SANGAMO THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for fiscal 2015 was $3.50M, a 61.54% decline from fiscal 2014.
- SANGAMO THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for fiscal 2014 was $9.10M, a 121.95% increase from fiscal 2013.
- SANGAMO THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for fiscal 2013 was $4.10M, a 4000.00% increase from fiscal 2012.
- SANGAMO THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for fiscal 2012 was $100.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested 12 month |
|---|---|
| 2015-12-31 | $3.50M 10-K · filed 2016-02-18 |
| 2014-12-31 | $9.10M 10-K · filed 2016-02-18 |
| 2013-12-31 | $4.10M 10-K · filed 2016-02-18 |
| 2012-12-31 | $100.00K 10-K · filed 2015-02-25 |